Immunotherapies Archives - Australian Biotech Company News

Home Tags Immunotherapies

Biotechnology

NK Cell Developer Cytovia Pursues SPAC Merger, Bucking the Bear Market

BioChannel - May 5, 2022

Biotechnology

Immune Cell Discovery May Bridge the Gap for Immunotherapy Resistance

BioChannel - April 21, 2022

Biotechnology

Vitamin E Can Enliven Dendritic Cells, Enhance Cancer Immunotherapy

BioChannel - April 15, 2022

Biotechnology

Understanding the Role of Polyfunctional Immune Cells in Cancer and Other...

BioChannel - March 23, 2022

Biotechnology

Efficacy of Polyfunctional GD3 CAR T Cells against Rare Tumors

BioChannel - February 22, 2022

Biotechnology

Engineering the Immune Response for Therapeutic Success

BioChannel - June 26, 2020

Biotechnology

Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation

BioChannel - June 1, 2020

Biotechnology

Brain Cancer CAR T Cell Therapy Guided by Scorpion Toxin Starts...

BioChannel - March 6, 2020

Biotechnology

GSK, Immatics Ink Up-to-$1B Cancer Immunotherapy Collaboration

BioChannel - February 20, 2020

Biotechnology

Engineered Probiotic Bacteria Deliver Anticancer Nanobodies to Regress Tumors in Mice

BioChannel - February 13, 2020

12 3 Page 1 of 3

Stay connected

Recent posts

Landmark $20 million gift received to establish Mount Sinai-Royalty Pharma Alliance for Health Equity...

BioChannel - May 16, 2022

Study provides long-term look at ways to control wildfire in sagebrush steppe ecosystem

BioChannel - May 16, 2022

Psychotropic Compound Synthesized from Rainforest Tree

BioChannel - May 16, 2022

Random article

Landmark $20 million gift received to establish Mount Sinai-Royalty Pharma Alliance...

Study provides long-term look at ways to control wildfire in sagebrush...

Psychotropic Compound Synthesized from Rainforest Tree

CRISPR Can Help The Switch To Sustainable Cosmetics